van der Doelen, Maarten J. http://orcid.org/0000-0001-8754-1210
Stockhaus, Agnes
Ma, Yuanjun
Mehra, Niven
Yachnin, Jeffrey
Gerritsen, Winald R.
Nilsson, Sten
van Oort, Inge M.
Ullén, Anders
Funding for this research was provided by:
Bayer HealthCare
Swedish Cancer Foundation
Cancerföreningen i Stockholm
Stiftelsen Konung Gustaf V:s Jubileumsfond
Stockholms Läns Landsting
Article History
Received: 29 January 2021
Accepted: 23 February 2021
First Online: 8 March 2021
Declarations
:
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local medical ethics committees and both hospital review boards. Informed consent was obtained from all individual participants included in the study.
: MJvdD discloses research grants and travel grants from Bayer, research grants from Janssen-Cilag, and received speaker fees from Astellas. AS declares research funding from Bayer. YM has no conflicts of interest to declare that are relevant to the content of this article. NM reports personal fees from Bayer, grants and personal fees from Jansen-Cilag, personal fees from MSD, grants and personal fees from Roche, grants and personal fees from Astellas, and grants and personal fees from Sanofi. JY has no conflicts of interest to declare that are relevant to the content of this article. WRG is a member of the advisory boards for Bristol-Myers Squibb, Astellas, Janssen, Bayer, Sanofi Genzyme, Amgen, Morphosys and CureVac, has received speaker fees from Bayer and MSD, and has received research funding from Astellas, Bayer, and Janssen. SN has participated as a member of advisory boards for Bayer, Astellas, Janssen, Sanofi Genzyme, and Amgen. IMvO received research grants and personal fees from Astellas, grants and personal fees from Bayer, grants and personal fees from Janssen-Cilag, and grants and personal fees from Sanofi. AU declares research funding from Bayer and Pierre-Fabre and is a member of the advisory boards for Pierre-Fabre, Roche, Pfizer, Merck, Janssen-Cilag, Astellas, and MSD.